Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S McConkey

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Journal of Clinical Microbiology|May 30, 2008
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virusM E Mendy, S Kaye, E Le Roux, et al.
Journal of Viral Hepatitis|October 31, 2009
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West AfricaM E Mendy, T Welzel, O A Lesi, et al.
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access programE Gray, A O'Leary, C Bergin, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Vaccine|February 21, 2006
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersD P Webster, S Dunachie, S McConkey, et al.
Vaccine|April 23, 2003
Safety of DNA and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteersV S Moorthy, S McConkey, M Roberts, et al.
Journal of Clinical Microbiology|May 30, 2008
Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virusM E Mendy, S Kaye, E Le Roux, et al.
Journal of Viral Hepatitis|October 31, 2009
Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West AfricaM E Mendy, T Welzel, O A Lesi, et al.
Expert Review of Gastroenterology & Hepatology|March 10, 2017
Effectiveness of interferon-free therapy for the treatment of HCV-patients with compensated cirrhosis treated through the Irish early access programE Gray, A O'Leary, C Bergin, et al.
Pageof 3